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High  concentrations  of adenosine  are  known to be toxic to fibroblasts  and 
lymphocytes under conditions of in vitro culture (1, 2). Normally, accumulation 
of adenosine nucleotides in all mammalian cells is prevented by the presence of 
adenosine deaminase,  an aminohydrolase which converts adenosine to inosine 
(3). A genetically determined deficiency of adenosine deaminase has been asso- 
ciated with the autosomal recessive form of severe combined immunodeficiency, 
a  syndrome in which precursor lymphocytes fail to mature into T  cells and B 
cells (4-7). Erythrocytes of affected infants convert exogenous adenosine to AMP 
and ATP at an abnormally increased rate as a consequence of the enzyme defect, 
and  fail  to form inosine  from the  exogenous  adenosine  (8).  These  metabolic 
disturbances can be mimicked in normal erythrocytes by coformycin (8), a potent 
competitive inhibitor of adenosine deaminase (9,  10). In this study, the effects of 
coformycin were examined on the in vitro function of normal lymphocytes. 
Materials and Methods 
Isolation  of Lymphocytes.  Lymphocytes were obtained from tonsils, thymuses, and peripheral 
blood.  Tonsils  from  children  (4-  to  10-yr  old)  undergoing elective tonsillectomy and  thymus 
biopsies (obtained with informed parental consent from children undergoing thoracic surgery) 
were teased into  single cell  suspensions. The cells  were filtered  through sterile  glass wool and 
washed before  fractionation  in RPMI-1640 medium containing antibiotics  as previously described 
(11).  Blood from normal adult donors was collected  in heparin (100  U/ml), and sedimented with 
dextran (1 ml of  6% Macrodex 70000/10 ml blood).  The leukocytes,  in medium TC-199 containing 
10% heat-inactivated  serum (from an AB + donor),  were passed over a column of  glass  beads which 
was prewarmed at  37°C and nonadhering cells  were collected  and washed three  times in  TC-199. 
Fractionation  of Lymphocytes.  Lymphocytes were suspended at a  concentration of no more 
than 10  ~ cells/ml in 17% bovine serum albumin. The cell suspension was added to the top of the 
gradient, centrifuged, and cells from each layer harvested (11). Purified B cells were prepared 
from layers seven and eight which were rosetted with sheep red cells (E), and nonrosetted cells 
were  retained  at  the  gradient  interface  in  Ficoll-Triosil  (density  1.080). After  fractionation 
procedures, cells were washed three times in medium TC-199  before use. 
Rosettes  with E.  Washed E  were adjusted to  1%  vol/vol concentration in  magnssium-free 
phosphate-buffered  saline. Suspensions of lymphocytes (2 ×  10  ~ cells/ml) containing 10% absorbed 
fetal calf serum were added to an equal volume of a  1% suspension of E. The suspensions were 
incubated at 37°C (20 min), centrifuged at 200 g (5 min), and stored at 4°C (at least 1-2 h). Rosettes 
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were counted in a  Neubauer hemocytometer. At least 200 lymphocytes were counted, and results 
are expressed as the nearest percenL 
Cellular Culture.  Lymphocytes were  suspended immediately after fractionation  in  medium 
RPMI-1640 supplemented with 15% heat-inactivated human  AB+  serum at 1 or 2  x  10" lympho- 
cytes/ml. 1 ml cultures in 16 x  125 mm plastic culture tubes were maintained at 37°C in 5% CO~ in 
air. 
Mitogens and  Antigens.  Bacto-phytohemagglutinin  P  (PHA)  (Difco  Laboratories,  Detroit, 
Mich.) and pokeweed  mitogen (PWM)  (Grand Island Biological  Co.,  Grand Island,  N.  Y.)  were 
used at a  final dilution of 1/100 of the stock solution.  Concanavalin A  (Con A) (Pharmacia Fine 
Chemicals, Uppsala,  Sweden)  was used at 5  ftg/ml of culture.  Tetanus toxoid (T.T.)  (Massachu- 
setts  Biological  Laboratory,  Boston,  Mass.)  was  used  at  a  concentration  of 10  pg/ml  culture. 
Lymphocyte mitogenic factor (LMF)  was produced and used as previously described (12). 
Measurement of['~H]Thymidine Incorporation.  Cellular proliferation was measured by count- 
ing TCA-precipitable  ['~Hlthymidine on filter paper disks which were assayed for radioactivity in 
duplicate (11). 
Irnmunoglobulin  G Synthesis.  B-cell or precursor lymphocyte populations were cultured at 2 
x  10" cells/ml in RPMI-1640 containing 15% human heat-inactivated serum from a  AB+ donor. On 
the 6th day of culture, cells were washed and resuspended in medium TC-199 (deficient in valine, 
leucine,  and  isoleucine)  to  which  2  tLCi/ml  1'4C|leucine,  and  1  t~Ci/ml  1'4C]valine  and 
p~C]isoleucine were  added.  2  days later  supernates were  harvested and newly formed IgG was 
measured (13).  Results are expressed as the difference in counts per minute of the goat antirabbit 
serum and the normal rabbit serum precipitates. 
Coformycin.  Coformycin  (9,  10)  was  a  gift  from  Dr.  H.  Umezawa  (Institute  of Microbial 
Chemistry, Tokyo, Japan).  Dilutions were made with saline and 0.1  ml of diluted solution was 
added  to  1-ml cultures.  Lymphocytes in culture  were  either exposed for  1/2 h  to  coformycin or 
during the entire course of the experiment. 
Results 
Effect  of Coformycin  on  T-  and B-Cell Functions.  When peripheral blood 
lymphocytes were  rosetted  with  E,  the  number  of E  rosettes  formed in  the 
presence of coformycin (37%) did not differ significantly from the number of E 
rosettes formed in the absence of coformycin (44%). Similarly, coformycin  had no 
effect on the rosetting of thymus cells. 
Coformycin in concentrations higher than  1  ×  10-:' M  inhibited the rate of 
[3H]thymidine incorporation into unfractionated blood lymphocytes, stimulated 
with PHA but had no effect when used in ion concentrations lower than 1 x  10  -~' 
M  (Table I). A  concentration of 1  x  10  -s M was chosen for all subsequent ex- 
periments. Coformycin did not inhibit responses to Con A, PWM, or T.T. 
TABLE  I 
Responses  of T Cells and B Cells 
Coformycin  0  10  :' M  10 " M  10 7 M  10 ~ M 
T-cellmitogens 
-  2,075  ± 492 
PHA*  106,720 ± 5,176 
Con A*  34,365  ±  1,002 
PWMT  88,352  ± 4,700 
T.T.*  119,214 ±  1,097 
B-cellmitogen 
LMF§  29,386  ± 526 
69,670 ±  4,792  107,373 ±  6,140  99,834 ±  3,678  92,816 ±  8,166 
31,236 ±  526  25,834 ±  212  32,746 ±  3,166  26,846 ±  6,658 
79,812 ±  3,911  77,983 ±  3,397  -  - 
113,221 ±  5,095  126,254 ±  4,524  -  - 
30,272  ±  120 
Results expressed in net counts per minute and per 10  ~ cells  plus one standard deviation. {'~H]thymidine 
incorporation measured on the  3rd (for  PHA, Con A, and PWM)  and the 7th  days  of  culture (for  T.T. and LMF 
plus T.T.). Controls = (average ± I SD) = 2,075 ± 492. 
* Unfractionated lymphocytes. 
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When purified B cells were cultured with T-cell LMF, the presence of  coformy- 
cin did not affect the proliferative response of B cells (Table I). IgG synthesis by 
LMF-stimulated B cells was similar in the presence of coformycin (1,324 cpm) or 
in its absence (1,160 cpm). 
Effects of Coformycin on Precursor Cells.  Cells with precursor characteris- 
tics  were  present  in  albumin  gradient  layers  1-3  of tonsil  lymphocytes (7). 
Inability  of  these  precursor  cells  to  react  with  E,  high  spontaneous 
[3H]thymidine incorporation, and inability to react with PHA were some of  their 
characteristics. All lymphoid cells in layer one of albumin gradients exhibited 
these characteristics, while cells from layers two and three were contaminated 
with T cells. 
Precursor cells differentiated during 10 days of culture into T cells (14) (Fig. 
1). The presence of coformycin inhibited the appearance of E-reactive cells (Fig. 
1). This inhibition did not correlate with the number of cells in culture nor with 
the number of dead cells. In a  typical example, on the 7th day, in the control 
culture, there were 5 ×  105 cells, 55% of which excluded trypan blue and 34% of 
which were E  positive.  In the coformycin-treated culture, there were 5  ×  105 
cells, 44% of which excluded trypan blue and only 1% of  which were E positive. 
The spontaneous incorporation of [~H]thymidine in precursor cells was de- 
creased by coformycin (Table II). Coformycin also inhibited PHA-induced prolif- 
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FIG.  1.  Effect of coformycin on E  reactivity of human precursor cells in culture. Results 
expressed in percents of E-rosetting lymphocytes at various time intervals of culture. (O) in 
the absence of, or (©) in the presence of  coformycin (10 -~ M). (Average results obtained from 
four different tonsil lymphocytes from albumin gradient layers one and two. Bars indicate 
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TABLE II 
Effect of Coformycin  on Spontaneous [3H]Thymidine  Incorporation  or Lectin Induced 
Proliferative  Response 
Exp.  1"  Exp. 25  Exp. 3§ 
Control  PHA  Control  PHA  Control  PHA 
In  the  absence  6,236  +- 457  5,185  -+  260  2,430  -+  164  37,943  _+ 3,121  3,181  -+ 60  48,930 _+  3,718 
of coformycin 
In the presence  1,434  _+  26  374  -+  141  1,636  -+  59  1,189  _+  52  440  -+  47  55,496 ±  4,663 
of coformycin 
Results expressed in net counts per minute and per 10  6 cells -+  one standard deviation. 
* PHA added on day 4, cultures harvested on day 7. 
5 PHA added on day 7, cultures harvested on day 10. 
§ PHA added on day 0, cultures harvested on day 7. 
erative responses of the precursor cells (Table II) when PHA was added to the 
culture on day 4 or day 7. However, in experiments where PHA was added at the 
beginning of culture, coformycin did not alter the proliferative response of the 
cells harvested after 7 or 10 days of culture. 
Precursor cells synthesized IgG at day 8 in culture in the presence of 1 x  10  -6 
M of coformycin, an amount that inhibited inception of E  rosetting and PHA 
proliferation (28,024 cpm vs.  19,680 cpm in control culture). 
Discussion and Summary 
A  limiting concentration of coformycin, 1  x  10  -~  M,  a  potent  inhibitor of 
adenosine deaminase, has no apparent effect on T- or B-cell function in vitro, 
although larger amounts of this drug inhibit proliferative responses to mito- 
gens. On the other hand, 1 x  10 -6 M of this inhibitor has a profound effect on 
precursor lymphocytes. Lymphoid cells, which have neither T- nor B-cell char- 
acteristics have been identified in blood, tonsils, bone marrow, and thymus and 
have been observed to mature under conditions of in vitro culture into typical T 
or  B  lymphocytes (14, 15). On  the  one  hand,  maturation of these  precursor 
lymphocytes into T  cells,  as  defined by E  rosetting,  and proliferation in the 
presence of PHA, is very sensitive to the presence of coformycin. On the other 
hand, maturation of precursor lymphocytes into immunoglobulin-secreting cells 
is not impaired by coformycin. The metabolic effects of coformycin which are 
ultimately responsible for the inhibition of T-cell maturation are not known at 
present. 
Infants affected with severe combined immunodeficiency  have lymphoid cells 
with precursor characteristics but no ~r very few mature T cells and B cells (7). 
The experiments reported here have mimicked in vitro the alterations observed 
in infants affected with this disease. From these findings it may be surmised 
that the B-cell defect in adenosine deaminase deficiency may be secondary to the 
failure  of T-cell  maturation.  Indeed,  the  B-cell  number  is  often  normal  in 
adenosine deaminase-deficient infants (5). A  child with a  genetically deter- 
mined deficiency of nucleoside phosphorylase, the next enzyme in the salvage 
pathway which converts inosine to hypoxanthine, has a  profound T-cell defi- 
ciency but normal numbers of B cells (16). Further studies of purine metabolism 
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effects of these metabolic disturbances induced by chemical inhibitors or geneti- 
cally determined enzyme deficiencies in the purine metabolic pathways. 
In  the  present  experiments,  it  was  observed  that  the  presence  of PHA  in 
cultures of precursor cells overcame the effects of coformycin. This was probably 
attributable  to  the  recruitment  effect of small  numbers  of cells  (2-6%)  which 
escaped the effect of coformycin and matured into T  cells. 
Received for publication 3 February 1976. 
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